A new trading day began on Monday, with Wave Life Sciences Ltd (NASDAQ: WVE) stock price up 147.26% from the previous day of trading, before settling in for the closing price of $7.49. WVE’s price has ranged from $5.28 to $15.72 over the past 52 weeks.
During the last 5-year period, the sales growth of Healthcare Sector giant was 34.27%. Meanwhile, its annual earnings per share averaged -69.15%. With a float of $134.97 million, this company’s outstanding shares have now reached $160.29 million.
Wave Life Sciences Ltd (WVE) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Wave Life Sciences Ltd is 19.27%, while institutional ownership is 82.42%. The most recent insider transaction that took place on Dec 08 ’25, was worth 1,730,601. Before that another transaction happened on Dec 08 ’25, when Company’s Director proposed sale 14,000 for $7.49, making the entire transaction worth $104,860.
Wave Life Sciences Ltd (WVE) Earnings and Forecasts
In its latest quarterly report, released on 12/31/2024, the company reported earnings of 0.27 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.31 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -69.15% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -17.82% during the next five years compared to 34.27% growth over the previous five years of trading.
Wave Life Sciences Ltd (NASDAQ: WVE) Trading Performance Indicators
Here are Wave Life Sciences Ltd’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 2.51. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 28.35.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.75, a number that is poised to hit -0.27 in the next quarter and is forecasted to reach -1.22 in one year’s time.
Technical Analysis of Wave Life Sciences Ltd (WVE)
Looking closely at Wave Life Sciences Ltd (NASDAQ: WVE), its last 5-days average volume was 31.45 million, which is a jump from its year-to-date volume of 2.36 million. As of the previous 9 days, the stock’s Stochastic %D was 81.11%.
During the past 100 days, Wave Life Sciences Ltd’s (WVE) raw stochastic average was set at 91.75%, which indicates a significant increase from 91.69% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.86 in the past 14 days, which was higher than the 0.56 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $7.72, while its 200-day Moving Average is $7.79. However, in the short run, Wave Life Sciences Ltd’s stock first resistance to watch stands at $21.17. Second resistance stands at $23.83. The third major resistance level sits at $28.05. If the price goes on to break the first support level at $14.29, it is likely to go to the next support level at $10.07. Should the price break the second support level, the third support level stands at $7.41.
Wave Life Sciences Ltd (NASDAQ: WVE) Key Stats
With a market capitalization of 3.10 billion, the company has a total of 167,182K Shares Outstanding. Currently, annual sales are 108,300 K while annual income is -97,010 K. The company’s previous quarter sales were 7,610 K while its latest quarter income was -53,850 K.
